Alex Pharma registers EGP 93.7M net profit in 8 months
Updated 4/10/2022 11:50:00 AM
ArabFinance: Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) has reported a net profit of EGP 93.718 million from July 1st 2021 to February 28th 2022, down from EGP 114.667 million in the same period a year earlier, according to a filing to the Egyptian Exchange (EGX) on Sunday.
The company posted operating revenue of EGP 747.355 million in the July-September period, down from EGP 787.707 million in the comparative period a year earlier.
Alex Pharma’s net profit after tax amounted to EGP 57.32 million in H1 FY 2021/2022, compared to a profit of EGP 79.005 million in H1 FY 2020/2021.
Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.
